This introductory dose allows your body to adjust to the medication before increasing to higher maintenance doses that may produce greater weight loss and metabolic benefits

local anesthetic applied Injection Points: Typically include the AC joint capsule and coracoclavicular ligament attachments Solution Used: 15-25% dextrose + 1% lidocaine or procaine Guidance: Can be done freehand or under ultrasound guidance for precision Post-Injection Care Mild soreness or swelling is expected for 13 days Avoid anti-inflammatory medications (they may blunt the desired response) Gentle range of motion exercises encouraged Physical therapy may be added at any time Treatment Frequency Prolotherapy is typically performed every 34 weeks 36 sessions are usually recommended depending on severity and how you are progressing Clinical Evidence Supporting Prolotherapy for AC Joint Injury While large randomized controlled trials are limited for AC separation specifically, prolotherapy has demonstrated efficacy in multiple musculoskeletal conditions involving ligament and joint instability: Rabago et al

PEPTIDE THERAPY CLINIC EL PASO, TX 20 targeted peptide protocols BPC-157, Sermorelin, CJC-1295/Ipamorelin, GHK-Cu, Tesamorelin, PT-141, Thymosin Alpha-1, and more prescribed and monitored by Celeste Cisneros, FNP-BC
Since a 1961 report by Paul O'Hollaren, MD, of Shadel Hospital in Seattle, Washington, NAD+ IV infusion has been widely utilized for the treatment of addiction (18-20)
Frequently Asked Questions: 1